METEOR
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

METEOR Trademark

Serial Number: 98058715

METEOR is a trademark filed by GammaDelta Therapeutics Ltd on June 26, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

GammaDelta Therapeutics Ltd (2 trademarks)

1 Kingdom Street

Entity Type: 77

Trademark Details

Filing Date

June 26, 2023

Registration Date

Not Registered

Goods & Services

Education services, namely, arranging and conducting classes, courses, seminars, conferences, congresses, symposiums, trainings and workshops in the fields of medicine, biochemical and biological materials and pharmaceuticals

Medical, biochemical, biological, and pharmaceutical preparations for use in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, haematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, urological diseases and disorders, viral diseases and disorders, rare diseases, namely, autoimmune rare diseases, bacterial infectious rare diseases, cardiological rare diseases, central and peripheral nervous systems rare diseases, diabetes rare diseases, endocrinological rare diseases, haematological rare diseases, hormonally originating rare diseases, gastroenterological rare diseases, gout rare diseases, infectious rare diseases, inflammatory rare diseases, musculoskeletal rare diseases, genetic rare diseases, neurological rare diseases, oncological cancer rare diseases, respiratory rare diseases, urological and kidney rare diseases, viral rare diseases for medical and pharmaceutical use

Biochemical and biological precursors for scientific purposes in relation to antibodies and multi-specific antibodies; biochemical and biological precursors for scientific purposes in relation to gamma delta t cells; biochemical and biological precursors for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; Biochemical and biological preparations for scientific and research purposes

Medical and scientific research and development services in the field of pharmaceutical products, biochemical and biological preparations; design, engineering, research, development, consultation and testing services in the field of pharmaceuticals, biochemical and biological preparations

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 5, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 5, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 21, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 21, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 21, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2025 CRFA
ASSIGNED TO LIE
Apr 28, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 10, 2025 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 7, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 2, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 2, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jul 2, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 19, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 19, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 19, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jun 19, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 11, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 11, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 13, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 13, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 13, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 12, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 26, 2023 NWOS
NEW APPLICATION ENTERED
Jun 29, 2023 NWAP